IRIS Accounts Production v23.2.0.158 13703697 Board of Directors 26.10.21 31.3.23 31.3.23 false true false false true false Ordinary 1.00000 Ordinary 1.00000 1.00000 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh137036972021-10-25137036972023-03-31137036972021-10-262023-03-31137036972021-10-2513703697ns10:Originalns15:EnglandWales2021-10-262023-03-3113703697ns14:PoundSterlingns10:Original2021-10-262023-03-3113703697ns10:Originalns10:Director12021-10-262023-03-3113703697ns10:Original2021-10-262023-03-3113703697ns10:Original2023-03-3113703697ns10:Originalns10:PrivateLimitedCompanyLtd2021-10-262023-03-3113703697ns10:Originalns10:SmallEntities2021-10-262023-03-3113703697ns10:Originalns10:AuditExempt-NoAccountantsReport2021-10-262023-03-3113703697ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2021-10-262023-03-3113703697ns10:SmallCompaniesRegimeForAccountsns10:Original2021-10-262023-03-3113703697ns10:Originalns10:FullAccounts2021-10-262023-03-3113703697ns10:Originalns10:OrdinaryShareClass12021-10-262023-03-3113703697ns10:Originalns10:OrdinaryShareClass22021-10-262023-03-3113703697ns10:Originalns10:OrdinaryShareClass112021-10-262023-03-3113703697ns10:Originalns10:OrdinaryShareClass2122021-10-262023-03-3113703697ns10:Originalns10:Director32021-10-262023-03-3113703697ns10:Originalns10:RegisteredOffice2021-10-262023-03-3113703697ns10:Originalns5:CurrentFinancialInstruments2023-03-3113703697ns5:ShareCapitalns10:Original2023-03-3113703697ns10:Originalns5:SharePremium2023-03-3113703697ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-03-3113703697ns10:Originalns5:PlantMachinery2021-10-262023-03-3113703697ns10:Originalns5:PlantMachinery2023-03-3113703697ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3113703697ns10:Originalns10:OrdinaryShareClass12023-03-3113703697ns10:Originalns10:OrdinaryShareClass22023-03-31
REGISTERED NUMBER: 13703697 (England and Wales)


















Unaudited Financial Statements

for the Period 26 October 2021 to 31 March 2023

for

Fungi Biotics Limited

Fungi Biotics Limited (Registered number: 13703697)






Contents of the Financial Statements
for the Period 26 October 2021 to 31 March 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Fungi Biotics Limited

Company Information
for the Period 26 October 2021 to 31 March 2023







DIRECTORS: A Broadhead
S Bessant





REGISTERED OFFICE: Lakeview House
4 Woodbrook Crescent
Billericay
Essex
CM12 0EQ





REGISTERED NUMBER: 13703697 (England and Wales)





ACCOUNTANTS: Mudd Partners LLP
Chartered Accountants
Lakeview House
4 Woodbrook Crescent
Billericay
Essex
CM12 0EQ

Fungi Biotics Limited (Registered number: 13703697)

Balance Sheet
31 March 2023

Notes £    £   
FIXED ASSETS
Tangible assets 4 8,511

CURRENT ASSETS
Stocks 8,150
Debtors 5 2,991
Cash at bank and in hand 84,434
95,575
CREDITORS
Amounts falling due within one year 6 5,201
NET CURRENT ASSETS 90,374
TOTAL ASSETS LESS CURRENT
LIABILITIES

98,885

CAPITAL AND RESERVES
Called up share capital 7 100
Share premium 119,980
Retained earnings (21,195 )
SHAREHOLDERS' FUNDS 98,885

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 16 October 2023 and were signed on its behalf by:





A Broadhead - Director


Fungi Biotics Limited (Registered number: 13703697)

Notes to the Financial Statements
for the Period 26 October 2021 to 31 March 2023

1. STATUTORY INFORMATION

Fungi Biotics Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 20% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 2 .

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
Additions 8,511
At 31 March 2023 8,511
NET BOOK VALUE
At 31 March 2023 8,511

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Other debtors 2,991

Fungi Biotics Limited (Registered number: 13703697)

Notes to the Financial Statements - continued
for the Period 26 October 2021 to 31 March 2023

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Trade creditors 2,401
Other creditors 2,800
5,201

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal
value: £   
80 Ordinary £1 100
20 Ordinary £1 -
100

80 Ordinary shares of £1 each were allotted and fully paid for cash at par during the period.

20 Ordinary shares of £1 each were allotted as fully paid at a premium of £5999 per share during the period.